C. Okereke

发表

Metabolism of benzophenone-3 in rats.

M. Abdel‐Rahman, C. Okereke, A. M. Kadry, 1993, Drug metabolism and disposition: the biological fate of chemicals.

Phase I Study of E7820, an Oral Inhibitor of Integrin α-2 Expression with Antiangiogenic Properties, in Patients with Advanced Malignancies

A. Tolcher, C. Takimoto, F. Giles, 2011, Clinical Cancer Research.

Pharmacokinetics of benzophenone‐3 after oral exposure in male rats

M. Abdel‐Rahman, C. Okereke, A. M. Kadry, 1995, Journal of applied toxicology : JAT.

Pharmacokinetics (PK) and pharmacodynamics (PD) of E7820-an oral sulfonamide with novel, alpha-2 integrin mediated antiangiogenic properties: Results of a phase I study

A. Tolcher, C. Takimoto, M. Mita, 2005 .

Advances in the use of carbapenem antibiotics in the management of serious bacterial infections in special patient populations. I: Safety and efficacy in children and elderly patients

C. Okereke, 2000 .

Safety evaluation of benzophenone-3 after dermal administration in rats.

M. Abdel‐Rahman, C. Okereke, S. Barat, 1995, Toxicology letters.

Disposition of benzophenone-3 after dermal administration in male rats.

C. Okereke, M. Friedman, M. S. Abdel-Rhaman, 1994, Toxicology letters.

Management of HIV-infected pregnant patients in malaria-endemic areas: therapeutic and safety considerations in concomitant use of antiretroviral and antimalarial agents.

C. Okereke, Chukwuemeka S. Okereke, 1999, Clinical therapeutics.

Beta-lactam/beta-lactamase inhibitor combinations: pharmacodynamic considerations and possible role in the management of bacterial infections in the neutropenic host.

C. Okereke, M. Dudley, 1998, The Journal of antimicrobial chemotherapy.

Lactam /-lactamase inhibitor combinations : pharmacodynamic considerations and possible role in the management of bacterial infections in the neutropenic host

C. Okereke, M. Dudley, 1998 .

Role of integrative pharmacokinetic and pharmacodynamic optimization strategy in the management of Parkinson"s disease patients experiencing motor fluctuations with levodopa.

C. Okereke, 2002, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.

Dinesh Kumar, C. Okereke, L. Kirby, 2004, British journal of clinical pharmacology.